Issue 35, 2018, Issue in Progress

Novel caged luciferin derivatives can prolong bioluminescence imaging in vitro and in vivo

Abstract

Based on N-cyclobutylaminoluciferin (cybLuc), a set of high and efficient caged bioluminescent derivatives (Clucs) as firefly luciferase pro-substrates has been developed herein. After careful examination, these molecules exhibited low cytotoxicity and prolonged bioluminescence imaging up to 6 h in vitro and in vivo. Importantly, these caged luciferin derivatives have the potential to serve as long-term tracking tools to explore some biological process by using bioluminescent imaging.

Graphical abstract: Novel caged luciferin derivatives can prolong bioluminescence imaging in vitro and in vivo

Supplementary files

Article information

Article type
Paper
Submitted
16 Mar 2018
Accepted
20 May 2018
First published
30 May 2018
This article is Open Access
Creative Commons BY license

RSC Adv., 2018,8, 19596-19599

Novel caged luciferin derivatives can prolong bioluminescence imaging in vitro and in vivo

C. Zhang, M. Yuan, G. Han, Y. Gao, C. Tang, X. Li, L. Du and M. Li, RSC Adv., 2018, 8, 19596 DOI: 10.1039/C8RA02312C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements